CAMKID Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP1-28803
Key Product Details
Species Reactivity
Human
Applications
Peptide ELISA, Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Goat IgG
Concentration
0.5 mg/ml
Product Specifications
Immunogen
Peptide with sequence ASQKDCAYVAKPES corresponding to C-Terminus according to NP_065130.1.
Epitope
internal region
Specificity
This antibody is expected to recognize reported isoform 1 (NP_065130.1).
Clonality
Polyclonal
Host
Goat
Isotype
IgG
Scientific Data Images for CAMKID Antibody
Western Blot: CAMKID Antibody [NBP1-28803]
Western Blot: CAMKID Antibody [NBP1-28803] - (0.5ug/ml) staining of Human Liver lysate (35ug protein in RIPA buffer). Primary incubation was 1 hour. Detected by chemiluminescence.Applications for CAMKID Antibody
Application
Recommended Usage
Peptide ELISA
Detection limit 1:4000
Western Blot
1 - 3 ug/ml
Application Notes
WB: Approx. 40 kDa band observed in human liver lysates (calculated MW of 40.2 kDa band according to NP_065130.1).
Formulation, Preparation, and Storage
Purification
Immunogen affinity purified
Formulation
Tris saline (20 mM Tris pH 7.3, 150 mM NaCl), 0.5% BSA
Preservative
0.02% Sodium Azide
Concentration
0.5 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at -20C. Avoid freeze-thaw cycles.
Background: CAMKID
Alternate Names
calcium/calmodulin-dependent protein kinase ID, calcium/calmodulin-dependent protein kinase type 1D, CaM kinase I delta, CaM kinase ID, CaM-K1, CaMKI delta, CaM-KI delta, CaMKID, CaMKI-like protein kinase, CKLiKEC 2.7.11.17, EC 2.7.11
Entrez Gene IDs
57118 (Human)
Gene Symbol
CAMK1D
UniProt
Additional CAMKID Products
Product Documents for CAMKID Antibody
Product Specific Notices for CAMKID Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...